HIV/AIDS Treatment News: January 2010
- Kaletra (Lopinavir/Ritonavir) Package Insert Revision Regarding Drug-Drug Interaction Information (January 29, 2010)
From U.S. Food and Drug Administration
- Videx EC/Videx (Didanosine) Label Change Reflects Potential for Serious Liver Disorder (January 29, 2010)
From U.S. Food and Drug Administration
- HIV Infection or Medications Age Brain (January 28, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- U.S. Food and Drug Administration Approves Labeling Update for Prezista to Include 96-Week Data in HIV-1 Infected Adult Patients (January 28, 2010)
From Tibotec Therapeutics
- Increased Presence, Severity of Coronary Artery Plaques in HIV-Infected Men (January 27, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Canada: Fewer HIV Patients Becoming Drug-Resistant -- B.C. Study (January 26, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Acyclovir and Transmission of HIV-1 From Persons Infected With HIV-1 and HSV-2 (January 25, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Journal of International AIDS Society Examines Efforts to Integrate HIV Treatment, Primary Care (January 22, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- AIDS and Depression: Ohio University Tests HIV Phone Therapy (January 21, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Maker of Reyataz and Sustiva Announces Enhancements to Co-Pay Benefit Program (January 21, 2010)
From TheBody.com
VIEW ALL ARTICLES
|
Advertisement
|